Skip to the reading
Hair Loss PeptideAbout

Similar peptide names can hide very different studies.

Once you’ve looked up one peptide, several more names tend to follow. We keep them separate here. Sharing a few letters, or even copper, doesn’t let one ingredient borrow another’s results. What happened in the experiment matters as much as what went into it.

A follicle outside the scalp is still a lab finding

Illustrative microscopy view of isolated hair follicles with attached hair fibres.
An illustrative view of hair follicles outside the scalp, rather than a treatment result.

AHK-Cu is a copper peptide, but it isn’t GHK-Cu with a spelling mistake. In a study of isolated human hair follicles and cells, researchers reported hair growth in follicles kept outside the body. Follicles are the structures hairs grow from.

That’s a lab finding. The word ‘human’ tells us where the tissue came from. It doesn’t mean the researchers treated people or established a safe way to use AHK-Cu for hair loss.

We’d leave the finding attached to AHK-Cu, too. It can’t answer whether GHK-Cu works on someone’s scalp. A related ingredient can be a reason for more research without supplying the missing answer.

Zinc-thymulin has an early report in people

A pilot study explored zinc-thymulin on the scalp in adults with pattern hair loss. It was open-label: the people taking part and the researchers knew what was being used. That’s useful context when reading an early report.

The report described it as well tolerated. A small early report can’t settle safety or show how much benefit someone could expect. Thymulin isn’t FDA-approved, and the human research is sparse. There’s no established routine to offer here.

Thymulin, thymosin alpha-1 and thymalin are different substances, despite the similar names. Research on one can’t stand in for research on another. It’s worth checking the exact name when a claim sends you looking for a paper.

A longer ingredient list isn’t more proof

A mixture needs evidence for that mixture. Separate studies of its ingredients can’t tell us how they’ll work together, or which one explains a change. We’d look for research on the actual combination in people with the relevant kind of hair loss.

The small GHK-combination trial is a useful example. It tested that lotion, rather than every mixture containing a peptide. A dermatologist or licensed clinician can help put the hair concern first and discuss care, including FDA-approved options where they exist. There’s room to be curious without deciding that a peptide has to be the answer.

The GHK-Cu page looks more closely at copper-peptide research. Safety and care covers questions about injections, cosmetics and medical care.